Yifeng Xiong

This inventor holds 39 USPTO granted patents and 24 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Pharmaceutical Modulators. Top assignees: Arena Pharmaceuticals, Inc., Contineum Therapeutics, Inc., Aries Associates, Inc.. Active years: 2006-2026.

USPTO Granted Patents = 39 (Patent Applications = 24)

% Patents Active = 71.8

CIPO Patents = 3 (Patent Applications = 9)

EPO Patents = 9 (Patent Applications = 20)

Average Co-Inventor Count = 7.5

ph-index = 10

Forward Citations = 343(Granted Patents)

Company Filing History:

30 out of 218

Arena Pharmaceuticals, Inc.

patents

3 out of 3

Contineum Therapeutics, Inc.

patents

2 out of 2

Aries Associates, Inc.

patents

4. 2 out of 1,561

Boehringer Ingelheim International Gmbh

patents

5. 2 out of 4

Pipeline Therapeutics, Inc.

patents

6. 2 out of 2

Radionetics Oncology, Inc.

patents

where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Muscarinic Acetylcholine

KISS1R

Cannabinoid Receptor

Serotonin Receptor

H3 Receptor

Metabolism Modulators

Pyrazole Derivatives

Fluorescent Labels

Aryl Derivatives

Heteroaryl Derivatives

Acetylcholine Antagonists

Therapeutics

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12685789 - Neuropeptide Y1 receptor (NPY1R) targeted therapeutics and uses thereof (2026-07-21),

2. 12565501 - Muscarinic acetylcholine Mreceptor antagonists (2026-03-03),

3. 12521455 - KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF (2026-01-13),

4. 12390462 - Muscarinic acetylcholine M1 receptor antagonists (2025-08-19),

5. 12115157 - 3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as medicament (2024-10-15),

6. 12109219 - Cannabinoid receptor modulators (2024-10-08),

7. 12054487 - Muscarinic acetylcholine Mreceptor antagonists (2024-08-06),

8. 11780827 - Substituted 3-phenoxyazetidin-1-yl-pyrazines (2023-10-10),

9. 11771695 - Cannabinoid receptor modulators (2023-10-03),

10. 11752149 - Muscarinic acetylcholine M1 receptor antagonists (2023-09-12),

11. 11746091 - Cannabinoid receptor modulators (2023-09-05),

12. 11512090 - Muscarinic acetylcholine Mreceptor antagonists (2022-11-29),

13. 11214548 - Cannabinoid receptor modulators (2022-01-04),

14. 10781180 - 3-phenyl-pyrazole derivatives as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto (2020-09-22),

15. 10632134 - Cannabinoid receptor modulators (2020-04-28),

Title: The Innovative Journey of Yifeng Xiong

Introduction: Yifeng Xiong, a talented inventor based in San Diego, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Yifeng Xiong holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Yifeng Xiong has successfully brought several cutting-edge inventions to life, revolutionizing industries and improving the lives of many.

Collaborations: Throughout his career, Yifeng Xiong has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the market, solidifying his reputation as a visionary inventor.

Conclusion: Yifeng Xiong's relentless pursuit of innovation and his dedication to pushing the boundaries of what is possible make him a true pioneer in the world of technology, with a promising future ahead.